Bruker (BRKR) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.49
- EPS estimate
- $0.38
- EPS surprise
- +27.34%
- Revenue surprise
- −1.77%
- Revenue
- $838.5M
- Revenue estimate
- $853.6M
- Reported
- Aug 4, 2026
Bruker reported Q2 2026 results on August 4, 2026. Earnings per share were $0.49, ahead of the $0.38 estimate by 27.34%. Revenue was $838.5 million, 1.77% short of the $853.6 million consensus. Compared with Q2 2025, EPS rose about 53% from $0.32 and revenue rose about 5% from $797.4 million.
The longer record shows growing sales but softer earnings. Annual EPS was $2.34 in 2022, $2.58 in 2023 and $2.41 in 2024, then fell about 24% to $1.83 in 2025. The first half of 2026 adds up to $0.80, almost level with $0.79 a year earlier. Revenue rose from $588.4 million in Q2 2022 to $838.5 million, about 43% higher. The fourth quarter is the largest of each year in the table, and Q4 2024 set the highs here at $0.76 per share and $979.6 million in revenue. Over the last 20 quarters, Bruker topped the EPS estimate 16 times. Its largest miss was Q2 2025, at 22.24% below.
Bruker reported Q3 results between November 1 and November 5 in each of the past five years. That points to early November 2026 for the next report, which will show whether the recent year-over-year EPS gains continue.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 4, 2026 | $0.38 | $0.49 | +27.34% | $838.5M | SEC |
| Q1 2026 | May 6, 2026 | $0.23 | $0.31 | +35.14% | $823.4M | SEC |
| Q4 2025 | Feb 12, 2026 | $0.65 | $0.59 | −9.90% | $977.2M | SEC |
| Q3 2025 | Nov 3, 2025 | $0.35 | $0.45 | +27.23% | $860.5M | SEC |
| Q2 2025 | Aug 4, 2025 | $0.41 | $0.32 | −22.24% | $797.4M | SEC |
| Q1 2025 | May 7, 2025 | $0.44 | $0.47 | +7.87% | $801.4M | SEC |
| Q4 2024 | Feb 13, 2025 | $0.74 | $0.76 | +3.13% | $979.6M | SEC |
| Q3 2024 | Nov 5, 2024 | $0.60 | $0.60 | −0.20% | $864.4M | SEC |
| Q2 2024 | Aug 6, 2024 | $0.51 | $0.52 | +1.31% | $800.7M | SEC |
| Q1 2024 | May 2, 2024 | $0.47 | $0.53 | +13.93% | $721.7M | SEC |
| Q4 2023 | Feb 13, 2024 | $0.68 | $0.70 | +2.44% | $854.5M | SEC |
| Q3 2023 | Nov 2, 2023 | $0.63 | $0.74 | +16.90% | $742.8M | SEC |
| Q2 2023 | Aug 3, 2023 | $0.49 | $0.50 | +2.71% | $681.9M | SEC |
| Q1 2023 | May 4, 2023 | $0.55 | $0.64 | +16.58% | $685.3M | SEC |
| Q4 2022 | Feb 9, 2023 | $0.72 | $0.74 | +2.44% | $708.4M | SEC |
| Q3 2022 | Nov 3, 2022 | $0.55 | $0.66 | +19.39% | $638.9M | SEC |
| Q2 2022 | Aug 3, 2022 | $0.45 | $0.45 | −0.35% | $588.4M | SEC |
| Q1 2022 | May 4, 2022 | $0.42 | $0.49 | +16.64% | $595.0M | SEC |
| Q4 2021 | Feb 11, 2022 | $0.59 | $0.59 | +0.84% | $683.5M | SEC |
| Q3 2021 | Nov 1, 2021 | $0.44 | $0.63 | +42.37% | $608.9M | SEC |
Quarterly revenue
Frequently asked questions
When did Bruker (BRKR) last report earnings?
Bruker last reported on Aug 4, 2026, covering fiscal Q2 2026.
Did BRKR beat earnings estimates?
Yes. Bruker reported EPS of $0.49 for Q2 2026 against a $0.38 estimate — a 27.34% beat.
How much revenue did BRKR report last quarter?
Bruker reported $838.5M in revenue for Q2 2026, against a consensus estimate of $853.6M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.